{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-10-09T12:22:38.672937+00:00",
  "news": [
    {
      "title": "Vertex Journavx: The Best Inventions of 2025 - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMif0FVX3lxTFBKdVVNN3JvejZnc084M1k0dmhrd1Yxa29LQV9oSVNKTUhBLTdPWHV4VDRlbUFZZE5vSVVIcVMtUmt1QllVU1FYaUV1VWo5ZXl4T3BNY08zUXRuTVRDbnpOaDFhbmg4UmhTbGRTWDM5T3RCalQxanNIWm1DUXJjbGM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMif0FVX3lxTFBKdVVNN3JvejZnc084M1k0dmhrd1Yxa29LQV9oSVNKTUhBLTdPWHV4VDRlbUFZZE5vSVVIcVMtUmt1QllVU1FYaUV1VWo5ZXl4T3BNY08zUXRuTVRDbnpOaDFhbmg4UmhTbGRTWDM5T3RCalQxanNIWm1DUXJjbGM?oc=5\" target=\"_blank\">Vertex Journavx: The Best Inventions of 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-10-09T11:23:48+00:00",
      "source": "Time Magazine"
    },
    {
      "title": "Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQU1R3dXFLbDRvMktVVTZkS2hoUzBZcFJWWlRPQVVoMHl3emZEVHBOcjRFem9EaEFtdTd4MlJJZmwzV3BQdkZ6VnpqOTRXd1U4cFdKWTl3d3oyaG5XSVh5LUI0S0ZyR2plNnBxaDJSWWxIZ29BZWk5aWFtenpBeW5BS2FocG16czFCU1d2VFlrSm42aTcxX1ZPeg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxQU1R3dXFLbDRvMktVVTZkS2hoUzBZcFJWWlRPQVVoMHl3emZEVHBOcjRFem9EaEFtdTd4MlJJZmwzV3BQdkZ6VnpqOTRXd1U4cFdKWTl3d3oyaG5XSVh5LUI0S0ZyR2plNnBxaDJSWWxIZ29BZWk5aWFtenpBeW5BS2FocG16czFCU1d2VFlrSm42aTcxX1ZPeg?oc=5\" target=\"_blank\">Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-08T13:00:03+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $530.00 Price Target at JPMorgan Chase & Co. - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQRXNwOEt3UzM4djNCZEFKcXRSelNRX1JJbUdfYTZlYjFXMWdHcE1aektoaXlyMmFGNzhUS0xMV3FreUJZOTZEX0NEZEdaRFdGY05oUGhGVXkzQXdEWE9iNlUwYlk0X3dDSUdZNlNaYkJTWmxhTzZQOFhHTGtMUGI3YUV2UzItWWhyWnJTQjFhbk96dDA3aF9pdzdYalZpM09mREFHNlRNTXJLTmNxUWNDYlFCb1NWN2EtdWxfcnc1Z09vWkhiWkUySWxBSVJrYU9MLS00?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQRXNwOEt3UzM4djNCZEFKcXRSelNRX1JJbUdfYTZlYjFXMWdHcE1aektoaXlyMmFGNzhUS0xMV3FreUJZOTZEX0NEZEdaRFdGY05oUGhGVXkzQXdEWE9iNlUwYlk0X3dDSUdZNlNaYkJTWmxhTzZQOFhHTGtMUGI3YUV2UzItWWhyWnJTQjFhbk96dDA3aF9pdzdYalZpM09mREFHNlRNTXJLTmNxUWNDYlFCb1NWN2EtdWxfcnc1Z09vWkhiWkUySWxBSVJrYU9MLS00?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $530.00 Price Target at JPMorgan Chase & Co.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-10-08T20:15:27+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors - Business Wire",
      "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNM2wtWlA2WHcxMnB4cTFNM1hGUEJJQ3MxVnFSbUhFYmp0SWdwS3BrcFRzeFpaMmkxWmVQQkdycXZsOXRPeU1TVm9lLXVqRDlHYmU1WUJKazVuQ2lXX1BXWExmcmVxLWlyVldnOEdoSDNRRVE1dzVKUUFTMmJQeWswYm42WThlOEliOW1HYm9SazRGQW5zVkpYbXM5VTBWcVZWOFdjUW01YWhhUFZIbExGUXdYcmtheFpZbVVueWpaRWdSTXdPVDlRbGJka05tWnVKVXUyQ2RFdVVFNDh0REtJcFF0ZFg4QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNM2wtWlA2WHcxMnB4cTFNM1hGUEJJQ3MxVnFSbUhFYmp0SWdwS3BrcFRzeFpaMmkxWmVQQkdycXZsOXRPeU1TVm9lLXVqRDlHYmU1WUJKazVuQ2lXX1BXWExmcmVxLWlyVldnOEdoSDNRRVE1dzVKUUFTMmJQeWswYm42WThlOEliOW1HYm9SazRGQW5zVkpYbXM5VTBWcVZWOFdjUW01YWhhUFZIbExGUXdYcmtheFpZbVVueWpaRWdSTXdPVDlRbGJka05tWnVKVXUyQ2RFdVVFNDh0REtJcFF0ZFg4QQ?oc=5\" target=\"_blank\">Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Wire</font>",
      "published": "2025-10-09T12:00:00+00:00",
      "source": "Business Wire"
    },
    {
      "title": "Vertex’s quest for a breakthrough in Type 1 diabetes - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNRHp0TUJXVlNnamdTNXNkUmJTOHNsRm1wVHU4d1FQMnktaTNKMFNnbEZKcEp2U3UtQXpMWmcxdXlDS3hjV0EyVWdTdkVDRHNqSDVFRkZnbFRKUTRnSG1qeEIxejZIaHh0NHVPemwtVW8zY2xTOWpRbkdSMi1qWTJzQnJuQ2s1S2tLOEJSQk9Vd2EwUWJZb3ZKN1RfNTVLS0RR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxNRHp0TUJXVlNnamdTNXNkUmJTOHNsRm1wVHU4d1FQMnktaTNKMFNnbEZKcEp2U3UtQXpMWmcxdXlDS3hjV0EyVWdTdkVDRHNqSDVFRkZnbFRKUTRnSG1qeEIxejZIaHh0NHVPemwtVW8zY2xTOWpRbkdSMi1qWTJzQnJuQ2s1S2tLOEJSQk9Vd2EwUWJZb3ZKN1RfNTVLS0RR?oc=5\" target=\"_blank\">Vertex’s quest for a breakthrough in Type 1 diabetes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-10-08T13:14:54+00:00",
      "source": "Pharma Voice"
    },
    {
      "title": "Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years - Sahm",
      "link": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNU2ZnSGxIbGI0RzJoTktyVlNuRzF1Z3N4SkFzWWoxSUNnNk1oanZWX2FrSWlqZ0xpRlQ2SEFDWE93U1I1TFlHdGxmTDFqUk1NV19EaExHRlQtbHRZbnNCeDNOM1dFTl9WaW9aN2tKMnQtc2NJWnVGZld0UjBWZ2RNQXhpalU3U2VWTWRfcWQ5d2xYT0xHMWZLa2pSM2dTeHFPbFRXLTdGcnFZOUJtLWZyMUw0b3BmMktjOVhoOThxcWdMTnhsQjAtelBlTExuWi03c2wtUVRTc2VUR2c?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNU2ZnSGxIbGI0RzJoTktyVlNuRzF1Z3N4SkFzWWoxSUNnNk1oanZWX2FrSWlqZ0xpRlQ2SEFDWE93U1I1TFlHdGxmTDFqUk1NV19EaExHRlQtbHRZbnNCeDNOM1dFTl9WaW9aN2tKMnQtc2NJWnVGZld0UjBWZ2RNQXhpalU3U2VWTWRfcWQ5d2xYT0xHMWZLa2pSM2dTeHFPbFRXLTdGcnFZOUJtLWZyMUw0b3BmMktjOVhoOThxcWdMTnhsQjAtelBlTExuWi03c2wtUVRTc2VUR2c?oc=5\" target=\"_blank\">Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Sahm</font>",
      "published": "2025-10-07T06:02:35+00:00",
      "source": "Sahm"
    },
    {
      "title": "Vertex Journavx - AOL.com",
      "link": "https://news.google.com/rss/articles/CBMia0FVX3lxTE5MWkRWMWVGVXpxTlhrYU4tUS1SajdoejNaVjByYmxHc2xoU2FJZTl6d0loSlNDelpxaXhLOGloRFR2aG03WUoyZnVTaS1fNzcwT2xXUU9HckxwdVhxcnh3THlBVUdCZUY1UWNZ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMia0FVX3lxTE5MWkRWMWVGVXpxTlhrYU4tUS1SajdoejNaVjByYmxHc2xoU2FJZTl6d0loSlNDelpxaXhLOGloRFR2aG03WUoyZnVTaS1fNzcwT2xXUU9HckxwdVhxcnh3THlBVUdCZUY1UWNZ?oc=5\" target=\"_blank\">Vertex Journavx</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AOL.com</font>",
      "published": "2025-10-09T11:19:48+00:00",
      "source": "AOL.com"
    },
    {
      "title": "Is Vertex Pharmaceuticals a Smart Investment After Recent FDA Approval for Sickle Cell Therapy? - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNSmxPTGZSV1FHN3dRekdybjFnR2tkdHFPZ2VwU0stQ1liZWJ4WmNIZzJOYy1oVjQ5b1A4THNoV2FPc2ozU1g2LTBQSXQ0WmtqdEZvQm91NkRIOGRBV0pUUDlXdHJ3UWE1NFlxajhJbHZUa01hSTNaSFZYU19XREF5MllqRWZVU216ZVBITTBYSmc1cDZEQ2xjclN4eHNfNlRGVEM0T0t1ZFg0aHJqS1ItdUJBOE1NbmFRVVYtYUpBS2ZfRFRyMm1ZRDdmQzhxZ01ub3NQamxEVUhrY1RwUnNQVzBxNE5pMFo2Znpueg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNSmxPTGZSV1FHN3dRekdybjFnR2tkdHFPZ2VwU0stQ1liZWJ4WmNIZzJOYy1oVjQ5b1A4THNoV2FPc2ozU1g2LTBQSXQ0WmtqdEZvQm91NkRIOGRBV0pUUDlXdHJ3UWE1NFlxajhJbHZUa01hSTNaSFZYU19XREF5MllqRWZVU216ZVBITTBYSmc1cDZEQ2xjclN4eHNfNlRGVEM0T0t1ZFg0aHJqS1ItdUJBOE1NbmFRVVYtYUpBS2ZfRFRyMm1ZRDdmQzhxZ01ub3NQamxEVUhrY1RwUnNQVzBxNE5pMFo2Znpueg?oc=5\" target=\"_blank\">Is Vertex Pharmaceuticals a Smart Investment After Recent FDA Approval for Sickle Cell Therapy?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-10-06T15:06:13+00:00",
      "source": "simplywall.st"
    }
  ],
  "product_launches": [
    {
      "title": "Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxNYTltcjN3Z2J3czZWRkNXWFMyQm10SzdfU0dtajd4UkJMRFZVOTlkTVpCTC1JMnpnUThEaTZSVnFFd3NZT3Z2NVFjM1ctTEhyOTJFa0pLdUc1QmxlVkUzeXljQnFKNnBiVDU5N2ZENXFfYnh6azR3TkNKRDg4QktEeDBNVFpHVDc1bVNnVVk1eVZIc0tMTEhNV2JUSWRZYlZyWTVxdmtyWE1pT0ZxM0poLXViTGRjc0RGenhoSkFZTDg0d1VfdVIzYWpnZ0dWVWRsX3puLWJEZUN6Q0tK?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNYTltcjN3Z2J3czZWRkNXWFMyQm10SzdfU0dtajd4UkJMRFZVOTlkTVpCTC1JMnpnUThEaTZSVnFFd3NZT3Z2NVFjM1ctTEhyOTJFa0pLdUc1QmxlVkUzeXljQnFKNnBiVDU5N2ZENXFfYnh6azR3TkNKRDg4QktEeDBNVFpHVDc1bVNnVVk1eVZIc0tMTEhNV2JUSWRZYlZyWTVxdmtyWE1pT0ZxM0poLXViTGRjc0RGenhoSkFZTDg0d1VfdVIzYWpnZ0dWVWRsX3puLWJEZUN6Q0tK?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-10-06T12:07:26+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQzRYUXFRSkhaTzlvRWhZSDFkVWs5RlhYNUV4TURuR2NmNFB6U2tvZEpYdFpwZ2VWUk5TekNMQ2tFMUdVS29FMWJBeXI4MW1zcFQzYk83MFRoOEFIdlA4QjJBLWJMZllBazJJX0JYbDdvVXJEZGJiYklTS09YUkNEXzJUbWxmVnZWLUdDcG8yeDJWb2xGcnFqSEwybW9HYWdqWV93SElPS1BqZGFMc0s4ZzFYcjhGaXV1?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQzRYUXFRSkhaTzlvRWhZSDFkVWs5RlhYNUV4TURuR2NmNFB6U2tvZEpYdFpwZ2VWUk5TekNMQ2tFMUdVS29FMWJBeXI4MW1zcFQzYk83MFRoOEFIdlA4QjJBLWJMZllBazJJX0JYbDdvVXJEZGJiYklTS09YUkNEXzJUbWxmVnZWLUdDcG8yeDJWb2xGcnFqSEwybW9HYWdqWV93SElPS1BqZGFMc0s4ZzFYcjhGaXV1?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-09-24T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-10-08",
      "close": 421.1499938964844
    },
    "history": [
      {
        "date": "2025-09-30",
        "close": 391.6400146484375
      },
      {
        "date": "2025-10-01",
        "close": 404.2099914550781
      },
      {
        "date": "2025-10-02",
        "close": 408.8500061035156
      },
      {
        "date": "2025-10-03",
        "close": 403.29998779296875
      },
      {
        "date": "2025-10-06",
        "close": 402.8999938964844
      },
      {
        "date": "2025-10-07",
        "close": 410.2799987792969
      },
      {
        "date": "2025-10-08",
        "close": 421.1499938964844
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}